Upstream Processing White Papers and Case Studies
-
Comparison Of Assay Methods For The Detection Of Residual Protein A In Biological Therapeutics
There continues to be a focus on the development of recombinant human monoclonal antibodies (rhuMAb IgGs) for therapeutic use with dozens reaching the market in the last decade.